News

FILTER BY:
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Surveillance: Fed owes mea culpa, says DudleySurveillance: Fed owes mea culpa, says Dudley
News

Surveillance: Fed owes mea culpa, says Dudley

October 10, 2022
Memory OEMs positioned to be winners in the long term, says Mizuho’s Vijay RakeshMemory OEMs positioned to be winners in the long term, says Mizuho’s Vijay Rakesh
News

Memory OEMs positioned to be winners in the long term, says Mizuho’s Vijay Rakesh

October 10, 2022
Toast is a safe bet for growth, says Mizuho’s Dan DolevToast is a safe bet for growth, says Mizuho’s Dan Dolev
News

Toast is a safe bet for growth, says Mizuho’s Dan Dolev

October 10, 2022
Most powerful women to watch: No. 2, Mizuho Americas' Michal KatzMost powerful women to watch: No. 2, Mizuho Americas' Michal Katz
News

Most powerful women to watch: No. 2, Mizuho Americas' Michal Katz

October 5, 2022
Mizuho hires Joseph O’Doherty as head of residential mortgage financeMizuho hires Joseph O’Doherty as head of residential mortgage finance
Press Release

Mizuho hires Joseph O’Doherty as head of residential mortgage finance

October 4, 2022
Buy ratings on Merck (MRK) & Tcr2 Therapeutics (TCRR)Buy ratings on Merck (MRK) & Tcr2 Therapeutics (TCRR)
News

Buy ratings on Merck (MRK) & Tcr2 Therapeutics (TCRR)

October 3, 2022
19th Hole: Interview with Jerry Rizzieri19th Hole: Interview with Jerry Rizzieri
News

19th Hole: Interview with Jerry Rizzieri

September 30, 2022
Mizuho Americas wins two LatinFinance Project & Infrastructure Finance awardsMizuho Americas wins two LatinFinance Project & Infrastructure Finance awards
Press Release

Mizuho Americas wins two LatinFinance Project & Infrastructure Finance awards

September 30, 2022
Biogen's Alzheimer’s drug could generate ‘$8 billion in peak sales’: AnalystBiogen's Alzheimer’s drug could generate ‘$8 billion in peak sales’: Analyst
News

Biogen's Alzheimer’s drug could generate ‘$8 billion in peak sales’: Analyst

September 29, 2022
back-to-top-blue